JP2018527305A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527305A5
JP2018527305A5 JP2017567465A JP2017567465A JP2018527305A5 JP 2018527305 A5 JP2018527305 A5 JP 2018527305A5 JP 2017567465 A JP2017567465 A JP 2017567465A JP 2017567465 A JP2017567465 A JP 2017567465A JP 2018527305 A5 JP2018527305 A5 JP 2018527305A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
drospirenone
daily
contraceptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017567465A
Other languages
English (en)
Japanese (ja)
Other versions
JP6827962B2 (ja
JP2018527305A (ja
Filing date
Publication date
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Application filed filed Critical
Priority claimed from PCT/EP2016/064574 external-priority patent/WO2016207298A1/en
Publication of JP2018527305A publication Critical patent/JP2018527305A/ja
Publication of JP2018527305A5 publication Critical patent/JP2018527305A5/ja
Application granted granted Critical
Publication of JP6827962B2 publication Critical patent/JP6827962B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017567465A 2015-06-23 2016-06-23 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬 Active JP6827962B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510348953.1 2015-06-23
EP15305965.4 2015-06-23
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (3)

Publication Number Publication Date
JP2018527305A JP2018527305A (ja) 2018-09-20
JP2018527305A5 true JP2018527305A5 (enExample) 2019-07-18
JP6827962B2 JP6827962B2 (ja) 2021-02-10

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567465A Active JP6827962B2 (ja) 2015-06-23 2016-06-23 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN113750108B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
JP6827962B2 (ja) 2015-06-23 2021-02-10 ラボラトリオス レオン ファーマ エスエー 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
GT200500099A (es) * 2004-04-30 2006-05-05 Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ES2311927T5 (es) 2005-07-21 2014-09-08 Bayer Pharma Aktiengesellschaft Proceso para la producción de 3-oxo-pregn-4-en-21,17-carbolactonas por la oxidación sin metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos
UY31010A1 (es) * 2007-04-05 2008-11-28 Bayer Schering Pharma Ag Nuevo régimen de drospirenona/17b-estradiol, producto farmacéutico combinado y conjunto de elementos (kit) para su aplicacion
CN102395596B (zh) * 2010-03-16 2013-02-13 台州太法药业有限公司 屈螺酮制备方法
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
JP6827962B2 (ja) 2015-06-23 2021-02-10 ラボラトリオス レオン ファーマ エスエー 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬

Similar Documents

Publication Publication Date Title
JP2013529665A5 (enExample)
HRP20240121T1 (hr) Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine
NZ605176A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
JP2016512248A5 (enExample)
WO2011160136A3 (en) Progesterone containing oral dosage forms and related methods
WO2013016697A3 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
RU2011103136A (ru) Фармацевтическая композиция на основе тонкоизмельченного прогестерона и ее применения
JP2015038135A5 (enExample)
UA116334C2 (uk) Тверді форми дозування бендамустину
WO2016210003A3 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2008084504A3 (en) Pharmaceutical compositions of angiotensin ii receptor blockers
JP2011502997A5 (enExample)
BR112012009857A2 (pt) composições farmacêuticas sólidas contendo um inibidor de integrase
HRP20250615T1 (hr) Tradipitant za upotrebu u liječenju gastropareze
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
HRP20240115T1 (hr) Povećavanje bioraspoloživosti lijeka u terapiji naltreksonom
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin
JP2020533296A5 (enExample)
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
RU2017127509A (ru) Композиции и способы для улучшенного мышечного метаболизма
JP2016512247A5 (enExample)
JP2018039810A5 (enExample)
JP2015521647A5 (enExample)
JP2016535762A5 (enExample)